S11E9: Dr. Lewis Blevins on Corcept's CATALYST Study: The Cortisol-Diabetes Link
Update: 2025-08-26
Description
In today's podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes. Results from this study, called CATALYST, were recently published by Corcept and presented at various scientific and medical conferences. Dr. Blevins explains the findings and offers his expert insight.
Comments
In Channel